![Cancers | Free Full-Text | The Evolution of Biomarkers in Thyroid Cancer—From Mass Screening to a Personalized Biosignature Cancers | Free Full-Text | The Evolution of Biomarkers in Thyroid Cancer—From Mass Screening to a Personalized Biosignature](https://www.mdpi.com/cancers/cancers-02-00885/article_deploy/html/images/cancers-02-00885-g001.png)
Cancers | Free Full-Text | The Evolution of Biomarkers in Thyroid Cancer—From Mass Screening to a Personalized Biosignature
![SciELO - Brasil - Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma SciELO - Brasil - Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma](https://minio.scielo.br/documentstore/1980-5322/3R5NJTvSjD9SCNcY5CdkWpN/803797c4ee5a2d4d47e99d34a8d89db5748291b4.gif)
SciELO - Brasil - Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma
![Cureus | Case Report: A Challenging Clinical Problem of Calcitonin-Negative Medullary Thyroid Cancer Diagnosis and Surveillance | Article Cureus | Case Report: A Challenging Clinical Problem of Calcitonin-Negative Medullary Thyroid Cancer Diagnosis and Surveillance | Article](https://assets.cureus.com/uploads/figure/file/507640/lightbox_91a9f680706b11edbe68f3d57b888e83-MTC-hp-pics-1.png)
Cureus | Case Report: A Challenging Clinical Problem of Calcitonin-Negative Medullary Thyroid Cancer Diagnosis and Surveillance | Article
![The neuropeptide calcitonin gene-related peptide links perineural invasion with lymph node metastasis in oral squamous cell carcinoma | BMC Cancer | Full Text The neuropeptide calcitonin gene-related peptide links perineural invasion with lymph node metastasis in oral squamous cell carcinoma | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-021-08998-9/MediaObjects/12885_2021_8998_Fig2_HTML.png)
The neuropeptide calcitonin gene-related peptide links perineural invasion with lymph node metastasis in oral squamous cell carcinoma | BMC Cancer | Full Text
![Frontiers | Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center Frontiers | Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center](https://www.frontiersin.org/files/Articles/747704/fendo-12-747704-HTML/image_m/fendo-12-747704-g001.jpg)
Frontiers | Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center
![Frontiers | Medullary Thyroid Carcinoma With Elevated Serum CEA and Normal Serum Calcitonin After Surgery: A Case Report and Literature Review Frontiers | Medullary Thyroid Carcinoma With Elevated Serum CEA and Normal Serum Calcitonin After Surgery: A Case Report and Literature Review](https://www.frontiersin.org/files/Articles/526716/fonc-10-526716-HTML/image_m/fonc-10-526716-g001.jpg)
Frontiers | Medullary Thyroid Carcinoma With Elevated Serum CEA and Normal Serum Calcitonin After Surgery: A Case Report and Literature Review
![Calcitonin as a Tumor Marker — Use of the Radioimmunoassay for Calcitonin in the Postoperative Evaluation of Patients with Medullary Thyroid Carcinoma | NEJM Calcitonin as a Tumor Marker — Use of the Radioimmunoassay for Calcitonin in the Postoperative Evaluation of Patients with Medullary Thyroid Carcinoma | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1974/nejm_1974.290.issue-19/nejm197405092901901/20130816/images/img_small/nejm197405092901901_f2.jpeg)
Calcitonin as a Tumor Marker — Use of the Radioimmunoassay for Calcitonin in the Postoperative Evaluation of Patients with Medullary Thyroid Carcinoma | NEJM
![Cancers | Free Full-Text | Preoperative Serum Calcitonin and Its Correlation with Extent of Lymph Node Metastasis in Medullary Thyroid Carcinoma Cancers | Free Full-Text | Preoperative Serum Calcitonin and Its Correlation with Extent of Lymph Node Metastasis in Medullary Thyroid Carcinoma](https://www.mdpi.com/cancers/cancers-12-02894/article_deploy/html/images/cancers-12-02894-g001.png)
Cancers | Free Full-Text | Preoperative Serum Calcitonin and Its Correlation with Extent of Lymph Node Metastasis in Medullary Thyroid Carcinoma
![High Ratio of Early Postoperative Calcitonin to Preoperative Calcitonin Could be a Novel Indicator of Poor Prognosis in Patients with Biochemical Incomplete Responses in Sporadic Medullary Thyroid Cancer - Endocrine Practice High Ratio of Early Postoperative Calcitonin to Preoperative Calcitonin Could be a Novel Indicator of Poor Prognosis in Patients with Biochemical Incomplete Responses in Sporadic Medullary Thyroid Cancer - Endocrine Practice](https://www.endocrinepractice.org/cms/attachment/4224a0ec-8757-4440-8cbf-58166db98b46/gr1.jpg)
High Ratio of Early Postoperative Calcitonin to Preoperative Calcitonin Could be a Novel Indicator of Poor Prognosis in Patients with Biochemical Incomplete Responses in Sporadic Medullary Thyroid Cancer - Endocrine Practice
American Journal of Case Reports | A Rare Case of Negative Serum Calcitonin in Metastatic Medullary Thyroid Carcinoma: Diagnosis, Treatment, and Follow-Up Strategy - Article abstract #935207
![Calcitonin as a Tumor Marker — Use of the Radioimmunoassay for Calcitonin in the Postoperative Evaluation of Patients with Medullary Thyroid Carcinoma | NEJM Calcitonin as a Tumor Marker — Use of the Radioimmunoassay for Calcitonin in the Postoperative Evaluation of Patients with Medullary Thyroid Carcinoma | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1974/nejm_1974.290.issue-19/nejm197405092901901/20130816/images/img_medium/nejm197405092901901_t1.jpeg)
Calcitonin as a Tumor Marker — Use of the Radioimmunoassay for Calcitonin in the Postoperative Evaluation of Patients with Medullary Thyroid Carcinoma | NEJM
![Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1575092215000327:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNf23BlP/DWEpPOpuWlfofnyU0Zzc7C+spQedaWXFRWdfa8E9RzH5OP6vqtd1YS/HjxOdTYJx4RbzWm1a7GceCWP3qYF4inzpywlsiBYzFsxK/QwT1Nm5JzzqbYwZvjC2q1Y6/y4423nzIlPJCY9uaPs2ZTbhP6Sb7en8QVZki5EDYklbWH3IwZb0lEkN4XZZudXAV2NXGAe+8oh+DoRQXjNMtX/hXtUlA3F/wvqP/Z25w+eWjEPrmJK3L+9gL4+cu0=)
Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for
![Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer - ScienceDirect Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0163725820302394-gr1.jpg)